Corporate Finance

The B Corp lender's record year reveals a surge in demand for energy upgrades and a deep commitment to making green tech accessible to lower-income families.

Backed by 1.2M citizens and 8 former world leaders, the 'My Voice, My Choice' initiative puts European democracy and reproductive rights at a crossroads.

A new partnership will bring Gentuity's high-resolution intravascular imaging to more U.S. cath labs, promising a new era of precision for heart procedures.

With strategic funding from Amex and Citi, Prophet Security's autonomous AI agents are set to redefine cyber defense against a new wave of AI-powered attacks.

With two strategic hires, Karoo Health signals a major push to dominate the value-based cardiac care market through tech innovation and national expansion.

A new partnership tackles AI's hidden bottleneck, using advanced interconnects to boost AMD-powered cloud performance, reliability, and efficiency.

With $280M in new funding, Beijing's Spirit AI is using real-world 'dirty data' to build a universal robot brain, challenging Google and Tesla.

Helm.ai claims its new vision-only AI can achieve urban autonomy, offering automakers a cheaper, scalable path from ADAS to certified Level 4 self-driving.

Amid rising constitutional debates, a major law firm's gift to the University of Miami School of Law aims to cultivate the legal minds of tomorrow.

Advantage Solutions overhauls its board, adding heavyweights in capital markets and commercial strategy to navigate a pivotal transformation and retail industry shifts.

After a mixed earnings report, ScanSource's CFO will outline the firm's pivot to recurring revenue and converging tech at a key investor conference.

For the eighth straight year, Magna5 lands on CRN's Elite 150 list, proving its mettle by evolving its cybersecurity, AI, and compliance services.

With funding from a mining giant, Finlay Minerals' latest results identify three major drill-ready copper-gold targets in BC's Toodoggone district.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

With its new HAE drug EKTERLY® smashing revenue forecasts, KalVista heads to key conferences where investors will scrutinize its path to profitability.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

Ex-Google and Salesforce leader David Keene joins Agentive as Co-Founder, betting on agentic AI to solve the costly complexity of modern B2B sales tools.

With sales rising and key FDA milestones met, Australian biotech Immuron resets its strategy, seeking partners to fund its promising infectious disease pipeline.

A new partnership between Amilia and CampDoc promises to eliminate data headaches for directors and enhance child safety through integrated, secure technology.

A new partnership between Salience Labs and Tower Semiconductor aims to mass-produce optical switches, a critical technology for faster, greener AI data centers.